VYST Vystar Corp.

Vystar Producing Vytex Latex Gloves For COVID-19 Prevention

Vystar Producing Vytex Latex Gloves For COVID-19 Prevention

  • Vytex disposable gloves are stronger, more puncture resistant and enhance tactile sensitivity and flexibility
  • All the advantages of latex while virtually eliminating risk of developing or triggering latex allergies
  • Sustainably sourced and completely biodegradable.

Worcester, MA, July 30, 2020 (GLOBE NEWSWIRE) -- Corporation (OTCQB: VYST) has contracted with a manufacturer in Thailand for the production of ultra-low protein Vytex natural rubber latex disposable gloves for workers and consumers to help prevent the spread of coronavirus via hand contact. Vytex disposable gloves offer superior tactile sensitivity, liquid barrier protection, puncture and tear resistance and flexibility -- all with virtually no risk of developing or experiencing latex allergies from extended contact. They are expected to be available for online purchase in September 2020.

The new disposable glove line offers many of the advantages of Vystar’s Vytex medical exam gloves that received a 510(k) clearance from the U.S. Food and Drug Administration (FDA) for medical use. Thanks to Vystar’s patented latex deproteinization process, disposable gloves made of Vytex latex are far superior to synthetic latex, nitrile, neoprene, and even traditional latex gloves as has been published in peer-reviewed industry journal articles.

“By removing 99.85% of all the proteins and non-rubber components that cause allergies, the resulting Vytex latex is ultra-pure and creates a stronger molecular bond which enables production of a 50% stronger, yet 50% thinner glove than competitors,” stated Steve Rotman, Vystar CEO. “In addition to helping prevent spread of infectious viruses such as Coronavirus and influenza to surfaces, essential workers in food service, and jobs requiring hand contact with other people, chemicals, delicate or fine parts, and materials will appreciate the improved tactile sensitivity and flexibility, as well as the extra protection from leaks, punctures and tears.”

“An added bonus is that Vytex is completely biodegradable and sustainably sourced – a major advantage considering the millions of workers who now use dozens of pairs of gloves daily,” Rotman remarked.

Most surgeons, healthcare and essential services workers who have to wear gloves daily prefer the superior tactile sensitivity, comfort and liquid barrier protection afforded by latex gloves, but the increased incidence of latex allergies caused by long term latex exposure has caused many healthcare facilities to ban or limit use of latex products. Since Vytex virtually eliminates risk of developing or triggering latex allergies, now workers and consumers can enjoy Vytex natural rubber latex’s functional advantages over other disposable glove materials minus the allergy worries.

Unexpected global increase in disposable glove use

Allied Market Research projects that the global , which was valued at $6.9 billion in 2019, is expected to reach $18.9 billion by 2027 at a CAGR of 13.1% during the forecast period. The disposable glove market has witnessed an unexpected growth due to COVID-19 outbreak. There is a rise in concern for safety, hygiene, and product quality. They noted mandated policies by agencies for companies to maintain worker safety, particularly in pharmaceutical, chemical, healthcare, oil and gas and automotive finishing will drive demand.

Vytex is ideal for more than 40,000 applications such as medical devices, gloves catheters and tubing; condoms; mattresses, toppers and pillows; cushions; balloons; adhesives; sports equipment, footwear; apparel and threads. For details on Vytex licensing, deproteinization or purchase, contact or 508-791-9114 or visit .

Follow Vystar and Vytex news on Twitter:

Hashtags #Coronavirus, #Covid, #disposablegloves, #medicalgloves, #latexgloves, #vystar, #vytex, #allergyfree, #hypoallergenic, #naturallatex

# # #

About Vystar Corporation:

Based in Worcester, Mass., Vystar® Corp. (OTCQB: VYST) is the majority owner of Furniture and Carpet and environmentally friendly technologies and products to improve lives, such as ® UV light air purification products, Natural Rubber Latex (NRL) and Fluid Energy Solutions. Vystar is the exclusive creator of Vytex, a multi-patented, all-natural, raw material that contains significantly reduced levels of the proteins found in natural rubber latex and can be used in over 40,000 products. Vytex NRL is a 100% renewable resource, environmentally safe, "green" and fully biodegradable. Vystar is working with manufacturers across a broad range of consumer and medical products bringing Vytex NRL to market in adhesives, gloves, balloons, condoms, other medical devices and natural rubber latex foam mattresses, toppers, and pillows. For more information, visit .

Contacts:

Media: Julie Shepherd, Accentuate PR, 847 275 3643,

Investors: Lee Howley,  508-791-9114

Distributor Opportunities: Steve Rotman, CEO,  508-791-9114

Forward-looking Statements: Investors are cautioned that certain statements contained in this document as well as some statements in periodic press releases and some oral statements of VYST officials are "Forward-Looking Statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act"). Forward-looking statements include statements which are predictive in nature, which depend upon or refer to future events or conditions, which include words such as "believes," "anticipates," "intends," "plans," "expects," and similar expressions. In addition, any statements concerning future financial performance (including future revenues, earnings or growth rates), ongoing business strategies or prospects, and possible future VYST actions, product development and delivery, which may be provided by management, are also forward-looking statements as defined by the Act. Forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance, or achievements expressed or implied by such forward-looking statements and to vary significantly from reporting period to reporting period. Although management believes that the assumptions made and expectations reflected in the forward-looking statements are reasonable, there is no assurance that the underlying assumptions will, in fact, prove to be correct or that actual future results will not be different from the expectations expressed in this report. These statements are not guarantees of future performance and VYST has no specific intention to update these statements.

Attachment

EN
30/07/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Vystar Corp.

 PRESS RELEASE

Vystar Develops Revolutionary Leap in Air Purification Utilizing its P...

Vystar Develops Revolutionary Leap in Air Purification Utilizing its Patented Hughes Reactor Boston, MA, May 09, 2025 (GLOBE NEWSWIRE) -- ® Corporation (OTCQB: VYST) Vystar has completed what it believes to be a revolutionary, next-generation RXAIR prototype using the new Fluid Energy Conversion - Hughes Reactor. The Hughes Reactor was developed by Dr. Bryan Stone, a Vystar board member. Vystar has been working on this new technology for the last several years and the device is now going for final pre-production testing. Fluid Energy Conversion’s (FEC) Technology - Nathanial Hughes, FEC’...

 PRESS RELEASE

Corporate Update

Corporate Update Boston, MA, April 30, 2025 (GLOBE NEWSWIRE) -- ® Corporation (OTCQB: VYST) Vystar received notice of final approval of its Form 15C-211 application. In addition, today the Company moved from the Pink Sheets to the OTCQB Exchange. The Company currently has 17,400,614 shares outstanding. This move marks an important milestone for Vystar as it allows for increased visibility and liquidity in the Company’s stock. Formal notice from the OTCQB will be circulated on Monday. Vystar wants to thank the outstanding staff at the OTC Markets Group for their time and diligence working...

 PRESS RELEASE

Vystar’s Subsidiary, Rotmans going out of business as Steve Rotman ret...

Vystar’s Subsidiary, Rotmans going out of business as Steve Rotman retires from Rotmans Furniture New England’s largest furniture and flooring store begins liquidation October 14 WORCESTER, Mass., Oct. 13, 2022 (GLOBE NEWSWIRE) -- Vystar® Corporation (OTCQB: VYST) – Rotmans, the largest furniture and flooring store in New England, announced it is going out of business and will begin total liquidation this week with the retirement of its president and CEO Steve Rotman. The going-out-of-business sale begins Friday, October 14, at 725 Southbridge St. and includes over $20 million of furnit...

 PRESS RELEASE

Vystar Adds Vytex into RxAir Spin-off, Sets Spin-Off Record Date, Open...

Vystar Adds Vytex into RxAir Spin-off, Sets Spin-Off Record Date, Opens Opportunity for Reverse Merger Into Vystar/Rotmans Vystar/Rotmans would have singular focus on furniture/bedding industry to be attractive reverse merger opportunityRxAir NewCo would include RxAir®, Vytex® and Fluid Energy ConversionRxAir NewCo dividend record date set for June 30, 2022After 100% RxAir NewCo spin-off, NewCo will issue 9.5% equity to Vystar Worcester, MA, Feb. 23, 2022 (GLOBE NEWSWIRE) -- ® Corporation (OTCQB: VYST) announces that it plans to split into two companies via a dividend. In addition ...

 PRESS RELEASE

Vystar Adds Fluid Energy Conversion Into Planned RxAir Spin-Off

Vystar Adds Fluid Energy Conversion Into Planned RxAir Spin-Off FEC patented technology has potential for applications in multiple industriesFEC to prioritize air and water purification R&D Worcester, MA, Sept. 20, 2021 (GLOBE NEWSWIRE) -- ® Corporation’s (OTCQB: VYST) Board of Directors has approved plans to add its Fluid Energy Conversion, Inc.(FEC), subsidiary into the previously announced planned spin-off of its ® UV light air purification subsidiary into a publicly traded entity (RxAir NewCo). This is expected to occur in early 2022. The addition of FEC to the RxAir spin-off w...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch